mc3r inhibition as a therapeutic strategy for treating hyperphagia in prader-willi syndrome
Published 2 years ago • 153 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
2:11
targeting the orexin system to treat prader-willi syndrome associated hyperphagia
-
1:59
orphan gpcrs and the neurobiology of hyperphagia in prader willi syndrome: role of gpr160
-
28:03
prader willi syndrome and other endocrinopathies in children with developmental disabilities
-
5:42
pbf-999 for the treatment of prader-willi syndrome
-
7:54
csti-500: a promising treatment for prader-willi syndrome (pws)
-
2:52
what is prader-willi syndrome?
-
6:22
acadia pharmaceuticals - clinical studies for hyperphagia in prader-willi syndrome
-
2:15
gene therapy of obesity in prader-willi syndrome by an autoregulatory bdnf vector
-
34:26
molecular insights and genetic therapy for pws
-
26:30
when and why to consider psych meds in pws
-
9:18
growth hormone treatment in prader-willi syndrome
-
1:51
prefrontal cortex mc4r neurons as a target for feeding and cognitive symptoms in pws.
-
1:03:59
dccr clinical trial update 2021
-
1:00:08
what's happening in pws research - fall 2022
-
4:33
what is the relationship between hyperphagia and the burden on caregivers?
-
15:21
prader-willi syndrome
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors